Literature DB >> 24401865

Treatment of angiofibromas in tuberous sclerosis complex: the effect of topical rapamycin and concomitant laser therapy.

Jin Park1, Seok-Kweon Yun, Yong-Sun Cho, Ki-Hun Song, Han-Uk Kim.   

Abstract

Facial angiofibromas are the most troublesome cutaneous manifestations of the tuberous sclerosis complex and are difficult to treat. Lasers are most commonly used to treat these skin lesions, but results are disappointing with frequent recurrences. Recently, treatment of facial angiofibromas with topical rapamycin has been reported to yield promising results. We observed the need of laser ablation in addition to topical rapamycin to get best results for the treatment of angiofibromas in 4 cases. The result showed that topical rapamycin ointment was enough when the papules were yet small in size, i.e. less than a few millimeters, but additional laser ablation was needed for large papules approximately larger than 4 mm. Considering the natural course of facial angiofibromas, we believe that topical rapamycin can be best used in childhood patients. In adults, topical rapamycin was useful for treating the still present small papules and for preventing recurrences after laser treatment.
© 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24401865     DOI: 10.1159/000357033

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

Review 1.  Pediatric Dermatology.

Authors:  Leslie Castelo-Soccio; Patrick McMahon
Journal:  J Clin Aesthet Dermatol       Date:  2017-03-01

Review 2.  [Benign skin neoplasms in children].

Authors:  Carmen Maria Salavastru; Alexandra-Irina Butacu; Klaus Fritz; Seher Eren; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-14       Impact factor: 0.751

Review 3.  [The most common benign cutaneous neoplasms of vascular, muscular, and adipose tissue and their treatment].

Authors:  Alexandra-Irina Butacu; Iulia-Elena Negulet; Emanuela-Domnica Boieriu; Ioana-Simona Dinu; Andrew Mihalache; Bogdan Mastalier; Carmen Maria Salavastru; Klaus Fritz; George-Sorin Tiplica
Journal:  Hautarzt       Date:  2022-01-18       Impact factor: 0.751

Review 4.  The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.

Authors:  Sean P Delaney; Lisa M Julian; William L Stanford
Journal:  Front Cell Dev Biol       Date:  2014-11-25

Review 5.  Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role.

Authors:  Michael A Cardis; Cynthia Marie Carver DeKlotz
Journal:  Arch Dis Child       Date:  2017-03-28       Impact factor: 3.791

6.  Topical Rapamycin for Facial Angiofibromas in a Child with Tuberous Sclerosis Complex (TSC): A Case Report and Long-Term Follow-up.

Authors:  Daniel Ebrahimi-Fakhari; Cornelia Sigrid Lissi Müller; Sascha Meyer; Marina Flotats-Bastardas; Thomas Vogt; Claudia Pföhler
Journal:  Dermatol Ther (Heidelb)       Date:  2017-02-08

7.  Comparison of the In Vitro and Ex Vivo Permeation of Existing Topical Formulations Used in the Treatment of Facial Angiofibroma and Characterization of the Variations Observed.

Authors:  Guillaume Le Guyader; Bernard Do; Victoire Vieillard; Karine Andrieux; Muriel Paul
Journal:  Pharmaceutics       Date:  2020-11-07       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.